Understanding medicine access strategies for innovator medicines registered in South Africa.

ABSTRACT:

Background

South Africa is composed of a two-tier healthcare system. One tier is a private healthcare system that is funded through medical insurance, and comprised of people who can afford to make monthly payments towards their medical insurance. Second tier is a government-funded public healthcare system, which covers the majority of the population. This study explored the perceived barriers and current strategies being utilised by the pharmaceutical industry to increase access to innovator medicines.

Objectives

The objectives of the study were to: (1) quantify and classify innovator medicines registered between 2010 and 2020 by the South African Health Products Regulatory Authority (SAHPRA); (2) identify barriers to accessing innovator medicines in South Africa through in

SUBMITTER: Jama TNQ 

PROVIDER: S-EPMC11468095 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature